Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs) are recommended for the medium- to long-term management of knee osteoarthritis (OA) due to their abilities to control pain, improve funct...
Saved in:
Main Authors: | Sukit Saengnipanthkul, Saranatra Waikakul, Sattaya Rojanasthien, Kitti Totemchokchyakarn, Attarit Srinkapaibulaya, Tai Cheh Chin, Nguyen Mai Hong, Olivier Bruyère, Cyrus Cooper, Jean Yves Reginster, Myat Lwin |
---|---|
格式: | 雜誌 |
出版: |
2019
|
主題: | |
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017162564&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65785 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Chiang Mai University |
相似書籍
-
Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment
由: Sukit Saengnipanthkul, et al.
出版: (2020) -
Budget impact analysis : an illustrative case of glucosamine in knee osteoarthritis
由: Jittrakul Leartsakulpanitch
出版: (2010) -
Budget impact analysis : an illustrative case of glucosamine in knee osteoarthritis
由: Jittrakul Leartsakulpanitch
出版: (2006) -
Glucosamine long-term treatment and the progression of knee osteoarthritis: Systematic review of randomized controlled trials
由: Nalinee Poolsup, et al.
出版: (2018) -
Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
由: Junaidi Khotib, -, et al.
出版: (2020)